Visual impairment in children with epilepsy treated with vigabatrin

Annals of Neurology

Volumn 48, Issue 1, 2000, Pages 60-64

  Gross Tsur, V ^a   Banin, E ^b   Shahar, E ^c   Shalev, R S ^a   Lahat, E ^d  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c RAMBAM MEDICAL CENTER   (Israel)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; FELBAMATE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; ELECTRORETINOGRAPHY; EPILEPSY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; VISUAL FIELD; VISUAL IMPAIRMENT;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; MALE; PERIMETRY; RETROSPECTIVE STUDIES; VIGABATRIN; VISION DISORDERS;

EID: 0033945713     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(200007)48:1<60::AID-ANA9>3.0.CO;2-E     Document Type: Article

References (31)

1. Ben-Menachem E. Vigabatrin. Epilepsia 1995;36(Suppl 2): S95-104
2. Meldrum BS. GABAergic mechanisms in the pathogenesis and treatment of epilepsy. Br J Clin Pharmacol 1989;27(Suppl):3s-11s
3. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systemic review of their efficacy and tolerability. Epilepsia 1997;38:859-880
4. Appleton RE. Vigabatrin in the management of generalized seizures in children. Seizure 1995;4:45-48
5. Chiron C, Dulac O, Luna L. Vigabatrin in infantile spasms. Lancet 1990;10:363-364
6. Lahat E. Vigabatrin in the treatment of pediatric epileptic syndromes. Harefuah 1995;128:306-308
7. Hancock E, Osborne JP. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 1999;14:71-74
8. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993;43:S21-23
9. Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:180-181
10. Wilson EA, Brodie MJ. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1693
11. Wong IC, Mawer GE, Sander JW. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1693-1694
12. Blackwell N, Hayllar J, Kelly G. Severe persistent visual field constriction associated with vigabatrin. BMJ 1997;314:1694
13. Krauss GL, Johnson MA, Miller NR. Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings. Neurology 1998;50:614-618
14. Arndt CF, Derambure P, Defoort-Dhellemmes S, Hache JC. Outer retinal dysfunction in patients treated with vigabatrin. Neurology 1999;52:1201-1205
15. Mackenzie R, Klistorner A. Asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ 1998;316:233
16. Vanhatalo S, Paakkonen L. Visual field constriction in children treated with vigabatrin. Neurology 1999;52:1713-1714
17. Bjelajac A, Gautam M, Logan WJ. Vigabatrin and ophthalmologic abnormalities in pediatric patients. Neurology 1999; 52(Suppl 2):A236 (Abstract)
18. Wohlrab G, Boltshauser E, Schmitt B, et al. Visual field constriction is not limited to children treated with vigabatrin. Neuropediatria 1999;30:130-132
19. Merin S, Shapira Y, Szabo G, Auerbach E. Electro-physiological studies of the visual system in mentally retarded children. J Pediatr Ophthalmol 1973;10:217-222
20. Guilford JP. Fundamental statistics in psychology and education. 5th ed. New York: McGraw-Hill, 1973:293-297
21. Steinhoff BJ, Freudenthaler N, Paulus W. The influence of established and new antiepileptic drugs on visual perception. II. A controlled study in patients with epilepsy under long-term antiepileptic medication. Epilepsy Res 1997;29:49-58
22. Harding GE. Severe persistent visual constriction associated with vigabatrin. BMJ 1998;315:232-233
23. Schmitz B, Jokiel B, Schmidt T, et al. Visual field defects under treatment with vigabatrin, carbamazepine and valproate. A prospective study. Epilepsia 1999;40(Suppl 2):257
24. Beran RG, Hung A, Plunkett M, et al. Predictability of visual field defects in patients exposed to GABAergic agents, vigabatrin or tiagabine. Neurology 1999;52(Suppl 2):A249 (Abstract)
25. Tasman W, Jaeger EA, eds. Duane's ophthalmology, vol 2. CD-ROM ed. Philadelphia: Lippincott-Raven, 1998
26. Schmidt T, Schmitz B, Jokiel B, et al. Constriction of the visual field in epilepsy patients taking vigabatrin and other antiepileptic drugs: a longitudinal study. Epilepsia 1999;40(Suppl 2):256
27. Butler WH, Ford GP, Newberne JW. A study of the effects of vigabatrin on the central nervous system and retina of Sprague-Dawley and Lister Hooded rats. Toxicol Pathol 1987;15:143-148
28. Petroff OA, Rothman DL, Behar KL, et al. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996;39:95-99
29. Petroff OAC, Hyder F, Mattson RH, Rothman DL. Topiramate increases brain GABA, homocarnosine and pyrrolidinone in patients with epilepsy. Neurology 1999;52:473-478
30. Daneshvar H, Racette L, Coupland SG, et al. Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 1999;106:1792-1798
31. Ruether K, Pung T, Kellner U, et al. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol 1998;116:817-819